Neumora Therapeutics NMRA
NASDAQ NMRA
$0.41 -0.01 (-2.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Neumora Therapeutics (NMRA) Return on Sales [ROS] (2023 - 2026)

Updated

Analysis

Neumora Therapeutics (NMRA) Return on Sales [ROS] (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 24.35%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 37.86%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 20.57%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 28.37%
10 Neumora Therapeutics 73.19 Mn -544.77 Mn - -4,512.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4,512.30%
Mar 31, 2026 -4,294.39%
Dec 31, 2025 -4,380.52%
Sep 30, 2025 -3,424.33%
Jun 30, 2025 -2,401.78%
Mar 31, 2025 -2,307.61%
Dec 31, 2024 -1,539.19%
Sep 30, 2024 -1,821.00%
Jun 30, 2024 -1,210.81%
Mar 31, 2024 -943.82%
Dec 31, 2023 -2,019.20%
Sep 30, 2023 -1,481.61%
Jun 30, 2023 -1,182.18%
Mar 31, 2023 -1,097.45%
API Access

Neumora Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NMRA&period=max&api_key=YOUR_API_KEY